Learn more

UNIV DER JOHANNES GUTENBERG UNIV MAINZ

Overview
  • Total Patents
    54
  • GoodIP Patent Rank
    28,935
  • Filing trend
    ⇧ 266.0%
About

UNIV DER JOHANNES GUTENBERG UNIV MAINZ has a total of 54 patent applications. It increased the IP activity by 266.0%. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are MCLEAN HOSPITAL CORP, MASSACHUSETTS GEN HOSPITAL and FORD HENRY HEALTH SYSTEM.

Patent filings per year

Chart showing UNIV DER JOHANNES GUTENBERG UNIV MAINZs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Rosigkeit Sebastian 5
#2 Schmitt Edgar 5
#3 Jonuleit Helmut 5
#4 Bockamp Ernst-Otto 5
#5 Brockmann Marc Alexander 4
#6 Vogelaar Christina Francisca 4
#7 Zipp Frauke 4
#8 Tanyildizi Yasemin 4
#9 Schuppan Detlev 4
#10 Lindemann Pascal 4

Latest patents

Publication Filing date Title
DE102019129288A1 Apparatus and method for determining the severity of sleep apnea
EP3750547A1 Modified nk-92 cells, and therapeutic and diagnostic uses thereof
DE102019112049A1 Finger movement splint for carrying out a continuous, passive and / or actively assisted movement of a finger and / or a thumb of a patient, as well as a therapy device comprising such a finger movement splint
DE102019112051A1 Length adjustment device for a finger movement splint, length adjustable finger movement splint and therapy device with at least one such length adjustable finger movement splint as well as a method for length adjustment
DE102019107666A1 Method for classifying a polysomnography recording into defined sleep stages
EP3715472A1 Phosphate and tensin homolog (pten) for the detection of autoimmune diseases or conditions
US2020174016A1 Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy
EP3646882A1 Pharmaceutical compositions, vaccines and their uses in the prevention or treatment of a persistent infection or of cancer
EP3643232A1 Apparatus and method for detecting neurological deficits
EP3639820A1 Flavagline derivatives for inhibition of kras oncogene activation
EP3566718A1 A pharmazeutical combination (treg depleting agent, checkpoint inhibitor, tlr9 agonist) for use in the treatment of cancer
EP3542814A1 Novel peptide-based compounds for use in the prevention, treatment and/or detection of cancer
EP3530320A1 Novel il-4-/il-13-derived peptide compounds for the treatment or prevention of neurodegenerative or neuroinflammatory diseases
EP3524266A1 Vaccine for use in the prevention or treatment of leishmaniasis
DE102017121251A1 catheter
EP3228266A1 A device for ultrasonic-accelerated hematoma lysis or thrombolysis of intracerebral or intraventricular hemorrhages or hematomas
EP3130678A1 In-vitro methods for the detection of treg resistance and autoimmune diseases
EP3072502A1 Rheological blood replacement solution and uses thereof
EP2977383A1 An in-vitro method and purification system for blood samples
US2016001026A1 Tracheal cannula and speaking-respiration system for mechanical respiration